Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Frontiers in microbiology · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Berta CuyàsDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.ORCID 0000-0001-9988-7163
Elisabet CantóInflammatory Diseases Department, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
Elisabet Sanchez-ArdidDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.
Elisenda MiróDepartment of Microbiology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.ORCID 0000-0003-2781-6926
Edilmar Alvarado-TapiasDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.
Eva RománDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.ORCID 0000-0001-9084-8555
Maria PocaDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.ORCID 0000-0002-0235-1395
Ferran NavarroDepartment of Microbiology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.ORCID 0000-0002-4302-2838
Andreu Ferrero-GregoriInflammatory Diseases Department, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0001-6492-2416
Maria Àngels EscorsellDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.ORCID 0000-0001-5083-8467
Silvia VidalInflammatory Diseases Department, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0002-3909-6682
German SorianoDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, C/Mas Casanovas 90, 08041 Barcelona, Spain.ORCID 0000-0002-9267-6811
Funding
Societat Catalana de Digestologia "Ajut per Iniciació a la Recerca"
6 · The paper itself
Abstract
Infections caused by multidrug-resistant organisms (MDRO) are linked to poor outcomes, particularly in patients with cirrhosis. The underlying mechanisms are not fully understood and may involve a different immune response against MDRO. This study aimed to compare the in vitro immune response between multidrug-resistant (MDR)
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
In Vitro Immune Response of Mononuclear Cells to Multidrug-Resistant · full record | OpenQuestion